We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Regulator or regulatory shield? The case for reforming Canada's Patented Medicine Prices Review Board.
- Authors
Rujun Zhang; Martin, Danielle; Naylor, C. David; Zhang, Rujun
- Abstract
The article talks about the Patented Medicine Prices Review Board of Canada, created for ensuring the price charged by patentees for patent medicines sold in Canada. Topics include boards' work such as ordering for price reduction and monitoring the spending on research and development by pharmaceutical patentees; increased Canada's expenditure involving patented drugs as a share of gross domestic product (GDP); and steps taken by Canada for improving negotiations with drug dealers.
- Subjects
PATENT medicines; DRUG prices; RESEARCH &; development; GROSS domestic product; NEGOTIATION
- Publication
Canadian Medical Association Journal (CMAJ), 2017, Vol 189, Issue 14, pE515
- Publication type
journal article
- DOI
10.1503/cmaj.161355